3 ABA Journal Regulatory Practice articles.
Social media offers cheap and targeted advertising that regulators don’t have the time or resources to fully monitor. Deceptive health claims that would land a company in court if made on television or radio are slipping by online.
Feb 1, 2020 1:45 AM CST
Aug 12, 2019 6:04 PM CDT
When the U.S. Food and Drug Administration was asked to approve Enovid for contraception, the “birth control pill” had already proved highly effective. But with legal and moral objections, a regulatory storm was gathering.
May 1, 2019 1:10 AM CDT